304 related articles for article (PubMed ID: 24788796)
21. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
[TBL] [Abstract][Full Text] [Related]
22. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
[TBL] [Abstract][Full Text] [Related]
23. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research].
Watanabe T; Fujimuro M
Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932
[TBL] [Abstract][Full Text] [Related]
24. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs.
Boyne JR; Jackson BR; Taylor A; Macnab SA; Whitehouse A
EMBO J; 2010 Jun; 29(11):1851-64. PubMed ID: 20436455
[TBL] [Abstract][Full Text] [Related]
25. Transcriptome analysis of Kaposi's sarcoma-associated herpesvirus during de novo primary infection of human B and endothelial cells.
Purushothaman P; Thakker S; Verma SC
J Virol; 2015 Mar; 89(6):3093-111. PubMed ID: 25552714
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
27. HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism.
Sei E; Wang T; Hunter OV; Xie Y; Conrad NK
PLoS Pathog; 2015 Feb; 11(2):e1004652. PubMed ID: 25710169
[TBL] [Abstract][Full Text] [Related]
28. Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing.
Majerciak V; Zheng ZM
Front Biosci (Landmark Ed); 2009 Jan; 14(4):1516-28. PubMed ID: 19273144
[TBL] [Abstract][Full Text] [Related]
29. Interactions between KSHV ORF57 and the novel human TREX proteins, CHTOP and CIP29.
Schumann S; Baquero-Perez B; Whitehouse A
J Gen Virol; 2016 Aug; 97(8):1904-1910. PubMed ID: 27189710
[TBL] [Abstract][Full Text] [Related]
30. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
31. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
32. Latent infection with Kaposi's sarcoma-associated herpesvirus enhances retrotransposition of long interspersed element-1.
Nakayama R; Ueno Y; Ueda K; Honda T
Oncogene; 2019 May; 38(22):4340-4351. PubMed ID: 30770900
[TBL] [Abstract][Full Text] [Related]
33. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
34. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus.
Majerciak V; Pripuzova N; McCoy JP; Gao SJ; Zheng ZM
J Virol; 2007 Feb; 81(3):1062-71. PubMed ID: 17108026
[TBL] [Abstract][Full Text] [Related]
35. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production.
Han Z; Swaminathan S
J Virol; 2006 Jun; 80(11):5251-60. PubMed ID: 16699005
[TBL] [Abstract][Full Text] [Related]
36. Site-specific association with host and viral chromatin by Kaposi's sarcoma-associated herpesvirus LANA and its reversal during lytic reactivation.
Mercier A; Arias C; Madrid AS; Holdorf MM; Ganem D
J Virol; 2014 Jun; 88(12):6762-77. PubMed ID: 24696474
[TBL] [Abstract][Full Text] [Related]
37. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis.
Pringle ES; Robinson CA; McCormick C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375594
[TBL] [Abstract][Full Text] [Related]
38. FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency.
Gao R; Li T; Tan B; Ramos da Silva S; Jung JU; Feng P; Gao SJ
J Virol; 2019 Feb; 93(3):. PubMed ID: 30404794
[TBL] [Abstract][Full Text] [Related]
39. Kaposi's Sarcoma-Associated Herpesvirus ORF68 Is a DNA Binding Protein Required for Viral Genome Cleavage and Packaging.
Gardner MR; Glaunsinger BA
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875246
[TBL] [Abstract][Full Text] [Related]
40. KSHV RNA-binding protein ORF57 inhibits P-body formation to promote viral multiplication by interaction with Ago2 and GW182.
Sharma NR; Majerciak V; Kruhlak MJ; Yu L; Kang JG; Yang A; Gu S; Fritzler MJ; Zheng ZM
Nucleic Acids Res; 2019 Sep; 47(17):9368-9385. PubMed ID: 31400113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
